Products

    Enfaport

    Complete nutrition for infants with chylothorax or LCHAD* deficiency and has DHA and ARA

    *LCHAD: Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency.

    Indication

    Enfaport is designed to meet the unique nutritional needs of infants with chylothorax or LCHAD deficiency. Enfaport balances high levels of medium-chain triglycerides (MCT) oil for easier absorption, and has DHA and ARA, important fatty acids for infant development.

    Ingredients

    Ingredients: Ready to Use: Nonfat milk, water, corn syrup solids, medium chain triglycerides (MCT oil), whey protein concentrate and less than 2%: Mortierella alpina oil*Crypthecodinium cohnii oil, soy oil, calcium carbonate, potassium chloride, magnesium chloride, magnesium phosphate, potassium phosphate, ferrous sulfate, calcium chloride, sodium chloride, zinc sulfate, cupric sulfate, manganese sulfate, potassium iodide, sodium selenite, soy lecithin, ascorbic acid, vitamin E acetate, niacinamide, calcium pantothenate, vitamin A palmitate, vitamin D3, thiamin hydrochloride, vitamin B6 hydrochloride, riboflavin, folic acid, vitamin K1, biotin, vitamin B12, choline chloride, inositol, carrageenan, mono- and diglycerides, taurine, L-carnitine.

    *A source of arachidonic acid (ARA).
    A source of docosahexaenoic acid (DHA).

    POTENTIAL ALLERGENS

    Enfaport contains milk and soy.

    Nutrients

    (Normal Dilution)

    Per 100 Calories

    Per 100 mL

     

    (3.3 fl oz)

    (3.3 fl oz)

    Protein, g

    3.5

    3.6

    Fat, g

    5.5

    5.6

    Linoleic acid, mg

    350

    360

    Carbohydrate, g

    10

    10.2

    Water, g

    83

    85

    Vitamins/Other Nutrients

       

    Vitamin A, IU

    350

    360

    Vitamin D, IU

    50

    51

    Vitamin E, IU

    4

    4.1

    Vitamin K, mcg

    12

    12.2

    Thiamin (Vitamin B1), mcg

    80

    81

    Riboflavin (Vitamin B2), mcg

    90

    92

    Vitamin B6, mcg

    68

    69

    Vitamin B12, mcg

    0.3

    0.31

    Niacin, mcg

    1000

    1020

    Folic acid (Folacin), mcg

    16

    16.3

    Pantothenic acid, mcg

    500

    510

    Biotin, mcg

    3

    3.1

    Vitamin C (Ascorbic acid), mg

    12

    12.2

    Choline, mg

    24

    24

    Inositol, mg

    17

    17.3

    Minerals

       

    Calcium, mg

    94

    96

    Phosphorus, mg

    52

    53

    Magnesium, mg

    8.8

    9

    Iron, mg

    1.8

    1.83

    Zinc, mg

    1

    1.02

    Manganese, mcg

    25

    25

    Copper, mcg

    75

    76

    Iodine, mcg

    15

    15.3

    Selenium, mcg

    2.8

    2.9

    Sodium, mg

    30

    31

    Potassium, mg

    115

    117

    Chloride, mg

    87

    89

    Nutrient Density

    30 Cal/fl oz

    Protein (% Calories)

    14

    Fat (% Calories)

    46

    Carbohydrate (% Calories)

    40

    Potential Renal Solute Load (mOsm/100 Calories)10

    28

    Potential Renal Solute Load (mOsm/100 mL)10

    29

    Osmolality (mOsm/kg water)

    360

    Osmolarity (mOsm/L)

    310

    Lactose-free

    No

    AMINO ACID COMPOSITION

    ESSENTIAL AMINO ACIDS

    mg/100 Cal

    Histidine

    88

    Isoleucine

    200

    Leucine

    370

    Lysine

    320

    Methionine

    81

    Cysteine

    64

    Phenylalanine

    147

    Tyrosine

    140

    Threonine

    210

    Tryptophan

    61

    Valine

    210

    NONESSENTIAL AMINO ACIDS

    mg/100 Cal

    Arginine

    105

    Alanine

    154

    Aspartic Acid

    340

    Glutamic Acid

    700

    Glycine

    70

    Proline

    280

    Serine

    200

    Product Forms and Ordering Information

    ENFAPORT IS AVAILABLE IN READY-TO-FEED LIQUID

    Coding systems and reimbursement allowable rates vary by payer:

    • Medicare Part B uses HCPCS (Healthcare Common Procedure Coding System) to group products
    • Medicaid systems vary by state; some use HCPCS while others use NDC format code or systems of their own—contact your state provider for more information
    • Private health insurance and managed care companies may use HCPCS, NDC format code or their own system—contact your provider for more information

    Enfaport, Ready-to-Feed
    Item #: 129601
    Description: RTF, 30 Cal/fl oz
    Unit Size: 6 fl oz bottle
    Calories/Unit: 180
    Product Yield/Unit (fl oz): 6
    Case: 24 bottles per case
    HCPCS Code: B4162
    NDC Format Code: 00087-5105-25

    PRODUCT BENEFITS

    Enfaport is designed to meet the unique nutritional needs of infants with chylothorax or LCHAD deficiency

    • Easy-to-digest 60:40 whey-to-casein ratio patterned after mature breast milk*1
    • 83% MCToil for easier fat absorption

    Has DHA and ARA, important nutrients also found in breast milk, to support brain and eye development2-9

    Additional product features:

    • Kosher

    *Comparison based on whey-to-casein ratio of typical mature breast milk (15 days to 6 months after birth).
    †% of total fat blend.

    Contact Mead Johnson

    Contact a Mead Johnson representative to request information and samples

    Layout:
    Help parents receive supplemental nutrition approved formulas
    Special Supplemental Nutrition Program for Women, Infants, and Children
    Additional special needs products
    Mead Johnson offers a range of products for infants, children and adults with special medical needs.

    References

    1. Kunz C, Lönnerdal B. Re-evaluation of the whey protein/casein ratio of human milk. Acta Paediatr. 1992;81:107-112.
    2. Birch EE, Hoffman DR, Uauy R, et al. Visual acuity and the essentiality of docosahexaenoic acid and arachidonic acid in the diet of term infants. Pediatr Res. 1998;44:201-209.
    3. Birch EE, Garfield S, Hoffman DR, et al. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol.2000;42:174-181.
    4. Birch EE, Hoffman DR, Castañeda YS, et al. A randomized controlled trial of long-chain polyunsaturated fatty acid supplementation of formula in term infants after weaning at 6 wk of age. Am J Clin Nutr. 2002;75:570-580.
    5. Hoffman DR, Birch EE, Castañeda YS, et al. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months: a randomized clinical trial. J Pediatr. 2003;142:669-677.
    6. Hoffman DR, Birch EE, Castañeda YS, et al. Maturation of visual and mental function in 18-month-old infants receiving dietary long-chain polyunsaturated fatty acids (LCPUFAs) [abstract]. FASEB J. 2003;17:A727-A728. Abstract 445.1.
    7. Hoffman DR, Birch EE, Birch DG, et al. Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development. J Pediatr Gastroenterol Nutr. 2000;31:540-553.
    8. Birch EE, Castañeda YS, Wheaton DH, et al. Visual maturation of term infants fed long-chain polyunsaturated fatty acid-supplemented or control formula for 12 mos. Am J Clin Nutr. 2005;81:871-879.
    9. Morale SE, Hoffman DR, Castañeda YS, et al. Duration of long-chain polyunsaturated fatty acids availability in the diet and visual acuity. Early Hum Dev. 2005;81:197-203.
    10. Fomon SJ, Ziegler EE. Renal solute load and potential renal solute load in infancy. J Pediatr. 1999;134:11-14.